Skip to main content
F

Formosa Laboratories, Inc. — Investor Relations & Filings

Ticker · 4746 TW Manufacturing
Filings indexed 1,860 across all filing types
Latest filing 2024-11-25 Regulatory Filings
Country TW Taiwan
Listing TW 4746

About Formosa Laboratories, Inc.

https://www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
113年11月法人說明會簡報 — 474620241125M001.pdf
Regulatory Filings
2024-11-25 Chinese
113年11月法人說明會簡報
Regulatory Filings
2024-11-25 Chinese
113年11月21日內部人設質解質
Regulatory Filings
2024-11-22 Chinese
本公司受邀參加凱基證券舉辦之法人說明會
Regulatory Filings
2024-11-21 Chinese
公告本公司董事會通過113年度第三季合併財務報告
Regulatory Filings
2024-11-14 Chinese
113年第3季海外子公司投資
Regulatory Filings
2024-11-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.